Increased blood pressure variability during the subacute phase of ischemic stroke is associated with poor functional outcomes at 3 months.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 01 2020
Historique:
received: 28 04 2019
accepted: 02 01 2020
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 15 12 2020
Statut: epublish

Résumé

Thus far, it is well known that increased blood pressure variability may exacerbate stroke outcomes. Blood pressure in the acute phase would be influenced by both reactive hypertension to stroke and intrinsic blood pressure reactivity. Thus, we aimed to evaluate the association between blood pressure variability and outcomes at 3 months using ambulatory blood pressure monitoring in ischemic stroke patients in the subacute phase after reactive hypertension subsided. We retrospectively examined 626 consecutive patients with acute ischemic stroke who underwent 24-hour ambulatory blood pressure monitoring during the subacute phase of stroke (median, 9 days from onset). The variability in blood pressure was evaluated by assessing the standard deviation and coefficient of variation of systolic and diastolic blood pressure. The primary outcome was functional status at 3 months. A poor outcome was defined as a modified Rankin scale score of 3 or more and a good outcome as 2 or less. We assessed the functional outcome at 3 months in 497 patients (79.4%). The mean systolic and diastolic blood pressure levels were not associated with functional outcome. The multivariable analysis revealed that increases in the standard deviations of systolic and diastolic blood pressure, coefficient of variation of diastolic blood pressure, and morning blood pressure surge were associated with poor outcome. Blood pressure variability during the subacute phase of ischemic stroke can be a useful prognostic indicator of poor functional outcome at 3 months in patients with acute ischemic stroke.

Identifiants

pubmed: 31964961
doi: 10.1038/s41598-020-57661-z
pii: 10.1038/s41598-020-57661-z
pmc: PMC6972830
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

811

Références

Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 360, 1903–1913 (2002).
pubmed: 12493255 doi: 10.1016/S0140-6736(02)11911-8
Yusuf, S. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 145–153 (2000).
pubmed: 10639539 doi: 10.1056/NEJM200001203420301
Tikhonoff, V., Zhang, H., Richart, T. & Staessen, J. A. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol. 8, 938–948 (2009).
pubmed: 19747655 doi: 10.1016/S1474-4422(09)70184-X
Willmot, M., Leonardi-Bee, J. & Bath, P. M. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension. 43, 18–24 (2004).
pubmed: 14662649 doi: 10.1161/01.HYP.0000105052.65787.35
Lawes, C. M., Bennett, D. A., Feigin, V. L. & Rodgers, A. Blood pressure and stroke: an overview of published reviews. Stroke. 35, 776–785 (2004).
pubmed: 14976329 doi: 10.1161/01.STR.0000116869.64771.5A
Ntaios, G., Bath, P. & Michel, P. Blood pressure treatment in acute ischemic stroke: a review of studies and recommendations. Curr Opin Neurol. 23, 46–52 (2010).
pubmed: 20038827 doi: 10.1097/WCO.0b013e328334e9d9
Robinson, T., Waddington, A., Ward-Close, S., Taub, N. & Potter, J. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis. 7, 264–272 (1997).
doi: 10.1159/000108206
Ntaios, G., Lambrou, D. & Michel, P. Blood pressure change and outcome in acute ischemic stroke: the impact of baseline values, previous hypertensive disease and previous antihypertensive treatment. J Hypertens. 29, 1583–1589 (2011).
pubmed: 21720273 doi: 10.1097/HJH.0b013e328348c957
Chung, J. W. et al. Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke. J Hypertens. 33, 2099–2106 (2015).
pubmed: 26237556 doi: 10.1097/HJH.0000000000000675
Ko, Y. et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke. 41, 2512–2518 (2010).
pubmed: 20947842 doi: 10.1161/STROKEAHA.110.595561
Kakaletsis, N. et al. Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis. Int J Stroke. 10, 1000–1007 (2015).
pubmed: 26283262 doi: 10.1111/ijs.12609
Qureshi, A. I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 118, 176–187 (2008).
pubmed: 18606927 doi: 10.1161/CIRCULATIONAHA.107.723874
Morfis, L., Schwartz, R. S., Poulos, R. & Howes, L. G. Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke. 28, 1401–1405 (1997).
pubmed: 9227691 doi: 10.1161/01.STR.28.7.1401
Christensen, H., Meden, P., Overgaard, K. & Boysen, G. The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand. 106, 142–147 (2002).
pubmed: 12174173 doi: 10.1034/j.1600-0404.2002.01356.x
Verdecchia, P. et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 81, 528–536 (1990).
pubmed: 2137047 doi: 10.1161/01.CIR.81.2.528
Coats, A. J. Reproducibility or variability of casual and ambulatory blood pressure data: implications for clinical trials. J Hypertens Suppl. 8, S17–20 (1990).
pubmed: 2081995
Stergiou, G. S. et al. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res. 37, 565–572 (2014).
pubmed: 24553366 doi: 10.1038/hr.2014.2
Tomii, Y. et al. Effects of 24-hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke. Stroke. 42, 3511–3517 (2011).
pubmed: 21960578 doi: 10.1161/STROKEAHA.111.628586
Aoki, S. et al. Blood pressure variability and prognosis in acute ischemic stroke with vascular compression on the rostral ventrolateral medulla (RVLM). Hypertens Res. 34, 617–622 (2011).
pubmed: 21346765 doi: 10.1038/hr.2011.17
Kitamura, J. et al. Blood Pressure Variability in Acute Ischemic Stroke: Influence of Infarct Location in the Insular Cortex. Eur Neurol. 79, 90–99 (2018).
pubmed: 29334680 doi: 10.1159/000486306
Harper, G., Castleden, C. M. & Potter, J. F. Factors affecting changes in blood pressure after acute stroke. Stroke. 25, 1726–1729 (1994).
pubmed: 8073450 doi: 10.1161/01.STR.25.9.1726
Kang, J. et al. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology. 79, 2018–2024 (2012).
pubmed: 23054228 pmcid: 3511921 doi: 10.1212/WNL.0b013e3182749eb8
Fukuda, K. et al. Day-by-day blood pressure variability and functional outcome after acute ischemic stroke: Fukuoka stroke registry. Stroke. 46, 1832–1839 (2015).
pubmed: 26069262 doi: 10.1161/STROKEAHA.115.009076
Yong, M., Diener, H. C., Kaste, M. & Mau, J. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 36, 2619–2625 (2005).
pubmed: 16254220 doi: 10.1161/01.STR.0000189998.74892.24
Yong, M. & Kaste, M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke. 39, 366–372 (2008).
pubmed: 18096843 doi: 10.1161/STROKEAHA.107.492330
Rocco, A. et al. Monitoring after the acute stage of stroke: a prospective study. Stroke. 38, 1225–1228 (2007).
pubmed: 17322080 doi: 10.1161/01.STR.0000259659.91505.40
Altamura, C. et al. The longitudinal changes of BOLD response and cerebral hemodynamics from acute to subacute stroke. A FMRI and TCD study. BMC Neurosci. 10, 151 (2009).
pubmed: 20021696 pmcid: 2805667 doi: 10.1186/1471-2202-10-151
Reinhard, M. et al. Dynamic cerebral autoregulation in acute ischemic stroke assessed from spontaneous blood pressure fluctuations. Stroke. 36, 1684–1689 (2005).
pubmed: 16020768 doi: 10.1161/01.STR.0000173183.36331.ee
Aries, M. J., Elting, J. W., De Keyser, J., Kremer, B. P. & Vroomen, P. C. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke. 41, 2697–2704 (2010).
pubmed: 20930158 doi: 10.1161/STROKEAHA.110.594168
Yano, Y. & Kario, K. Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events. Curr Hypertens Rep. 14, 219–227 (2012).
pubmed: 22528841 doi: 10.1007/s11906-012-0261-z
Kamouchi, M. et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 42, 2788–2794 (2011).
pubmed: 21817134 doi: 10.1161/STROKEAHA.111.617415
Webb, A. J., Fischer, U., Mehta, Z. & Rothwell, P. M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 375, 906–915 (2010).
pubmed: 20226989 doi: 10.1016/S0140-6736(10)60235-8
Naito, H. et al. Controlling nutritional status score for predicting 3-mo functional outcome in acute ischemic stroke. Nutrition. 55–56, 1–6 (2018).
pubmed: 29980088 doi: 10.1016/j.nut.2018.02.025
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 39, S1–S266 (2002).
Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24, 35–41 (1993).
pubmed: 7678184 doi: 10.1161/01.STR.24.1.35
Kario, K. et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 107, 1401–1406 (2003).
pubmed: 12642361 doi: 10.1161/01.CIR.0000056521.67546.AA
Kario, K. et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 38, 852–857 (2001).
pubmed: 11641298 doi: 10.1161/hy1001.092640
DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44, 837–845 (1988).
pubmed: 3203132 doi: 10.2307/2531595

Auteurs

Hiroyuki Naito (H)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Naohisa Hosomi (N)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. nhosomi@hiroshima-u.ac.jp.

Daisuke Kuzume (D)

Department of Neurology, Chikamori Hospital, Kochi, Japan.

Tomohisa Nezu (T)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Shiro Aoki (S)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yuko Morimoto (Y)

Department of Neurology, Chikamori Hospital, Kochi, Japan.

Masato Kinboshi (M)

Department of Neurology, Chikamori Hospital, Kochi, Japan.

Takeshi Yoshida (T)

Department of Rheumatology, Chikamori Hospital, Kochi, Japan.

Yuji Shiga (Y)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Naoto Kinoshita (N)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Hiroki Ueno (H)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Kensuke Noma (K)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Masahiro Yamasaki (M)

Department of Neurology, Chikamori Hospital, Kochi, Japan.

Hirofumi Maruyama (H)

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH